Abbott Laboratories (ABT) financials

Healthcare Equipment · NYSE · Health Care

$106.20 +1.56% Close Oct 30, 2026 Live

Abbott Laboratories revenue and earnings by year

Abbott Laboratories's revenue was $44.3 billion in the fiscal year to December 31, 2025, up 5.7% from the year before. Net income was $6.52 billion, 14.7% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 8.7% a year on average.

RevenueNet income
$20.0B$40.0B
2016201720182019202020212022202320242025

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 10 fiscal years

In billions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Revenue44.342.040.143.743.134.631.930.627.420.9
Revenue growth5.7%4.6%-8.1%1.3%24.5%8.5%4.3%11.6%31.3%—
Gross profit25.023.222.124.524.519.618.717.915.011.8
Gross margin56.4%55.4%55.2%56.1%57.0%56.6%58.5%58.4%54.7%56.4%
Operating income8.16.86.58.48.45.44.53.71.63.0
Operating margin18.2%16.3%16.2%19.2%19.6%15.5%14.2%11.9%5.7%14.5%
Net income6.513.45.76.97.14.53.72.40.51.4
Net margin14.7%31.9%14.3%15.9%16.4%13.0%11.6%7.7%1.7%6.7%
Diluted EPS$3.72$7.64$3.26$3.91$3.94$2.50$2.06$1.33$0.26$0.93
Free cash flow7.46.45.17.88.65.74.54.94.42.1

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open ABT in Markets.

See also: ABT valuation and P/E history · ABT returns

No forecast, no recommendation. This page describes Abbott Laboratories from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.